The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis
Abstract Background Rare diseases (RDs) affect less than 5/10,000 people in Europe and fewer than 200,000 individuals in the United States. In rheumatology, RDs are heterogeneous and lack systemic classification. Clinical courses involve a variety of diverse symptoms, and patients may be misdiagnose...
Main Authors: | Judith Leyens, Tim Th. A. Bender, Martin Mücke, Christiane Stieber, Dmitrij Kravchenko, Christian Dernbach, Matthias F. Seidel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-021-01945-8 |
Similar Items
-
Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis
by: Tim T. A. Bender, et al.
Published: (2020-10-01) -
Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor
by: T. Aguiar, et al.
Published: (2016-05-01) -
HISTORY OF ANKYLOSING SPONDYLITIS: THE JOURNEY FROM DINOSAURS TO ASAS
by: Shandor F Erdes
Published: (2014-03-01) -
Spectrum of interstitial lung disease in rheumatic diseases
by: Gouri Koduri, et al.
Published: (2021-01-01) -
Outcome of Pregnancy in Less Common Rheumatic Diseases: Inflammatory Myositis, Systemic Sclerosis and Vasculitis
by: Upendra Rathore, et al.
Published: (2021-07-01)